Table 3. Methods used by national reference or expert laboratories for species identification, phenotypic carbapenem susceptibility testing and genotypic characterisation of carbapenem-resistant Acinetobacter baumannii (CRAb), European countries, 2019 (nā=ā37).
| Country | Method for  species determination  | 
Method for phenotypic  carbapenem susceptibility testing  | 
Method for genotypic characterisation  of carbapenem resistance  | 
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biochemical | MALDI-TOF | PCR/gene sequencing | WGS | Automated system | Disc diffusion | Gradient test | Commercial broth microdilution | Agar dilution | In-house broth microdilution | PCR | Real-time PCR | Single-gene sequencing | WGS | Other | ||
| Albania | Yes | No | No | No | Yes | Yes | Yes | No | No | No | Not performed | |||||
| Austria | Yes | Yes | Yes | No | No | Yes | Yes | Yes | No | No | Yes | No | No | No | Yesa | |
| Belgium | No | Yes | Yes | Yes | No | Yes | No | Yes | No | No | Yes | No | Yes | Yes | No | |
| Bosnia and Herzegovinab | No NRL or expert laboratory | |||||||||||||||
| Bulgaria | Yes | No | Yes | No | No | Yes | No | Yes | No | No | Yes | No | No | No | No | |
| Croatia | No NRL or expert laboratory | |||||||||||||||
| Cyprus | No NRL or expert laboratory | |||||||||||||||
| Czechia | Yes | Yes | No | No | No | Yes | Yes | Yes | No | No | Yes | No | Yes | Yes | No | |
| Denmark | No | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | No | No | No | No | Yes | No | |
| Estonia | No NRL or expert laboratory | |||||||||||||||
| Finland | No | No | No | Yes | Yes | Yes | Yes | No | No | No | No | No | No | Yes | No | |
| France | No | Yes | Yes | No | No | Yes | Yes | Yes | No | Yes | Yes | No | Yes | Yes | No | |
| Germany | No | Yes | Yes | No | No | Yes | Yes | Yes | No | No | Yes | No | Yes | Yes | No | |
| Greece | No NRL or expert laboratory | |||||||||||||||
| Hungary | No | Yes | Yes | No | No | Yes | Yes | No | No | Yes | Yes | No | No | Yes | No | |
| Iceland | No | Yes | Yes | No | No | Yes | Yes | Yes | No | No | Yes | Yes | No | Yes | Yesc | |
| Ireland | No | Yes | No | No | No | No | Yes | No | No | No | No | Yes | No | No | No | |
| Italyd | Yes | No | Yes | Yes | No | Yes | Yes | Yes | No | No | Yes | No | Yes | Yes | No | |
| Kosovoe | Yes | No | No | No | Yes | Yes | Yes | Yes | No | No | Not performed | |||||
| Latvia | Yes | Yes | No | No | Yes | No | Yes | No | No | No | No | Yes | No | No | No | |
| Lithuania | No | Yes | No | No | No | Yes | No | Yes | No | No | Not performed | |||||
| Luxembourg | No | Yes | No | No | No | Yes | No | Yes | No | No | No | Yes | No | Yes | No | |
| Malta | No | Yes | No | No | Yes | No | No | No | No | No | Not performed | |||||
| Montenegro | No NRL or expert laboratory | |||||||||||||||
| The Netherlands | No | Yes | No | No | Yes | No | No | No | No | No | Yes | No | No | Yes | No | |
| North Macedonia | Yes | N | No | No | Yes | Yes | Yes | No | No | No | No | Yes | No | No | No | |
| Norway | No | Yes | Yes | Yes | No | No | No | Yes | No | No | Yes | No | No | Yes | No | |
| Poland | Yes | No | No | No | No | Yes | Yes | No | No | Yes | Yes | No | No | No | No | |
| Portugal | No | Yes | Yes | No | No | Yes | No | No | No | Yes | Yes | No | Yes | Yes | No | |
| Romania | Yes | Yes | Yes | No | No | Yes | No | No | No | No | Yes | No | Yes | No | No | |
| Serbia | No | Yes | No | No | No | Yes | Yes | Yes | No | No | Yes | No | No | No | No | |
| Slovakia | No NRL or expert laboratory | |||||||||||||||
| Slovenia | No | Yes | Yes | No | No | Yes | Yes | Yes | No | No | Yes | Yes | No | Yes | No | |
| Spain | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | No | |
| Sweden | No | Yes | No | Yes | No | No | No | Yes | No | No | No | No | No | Yes | No | |
| Turkey | No | Yes | Yes | No | No | Yes | Yes | No | Yes | Yes | Yes | No | No | No | No | |
| UK | England | No | Yes | Yes | No | No | No | Yes | Yes | No | No | Yes | Yes | No | No | No | 
| Northern Ireland | See UK ā England | |||||||||||||||
| Scotland | Yes | No | No | No | No | No | No | Yes | No | No | Not performed | |||||
| Wales | No | Yes | No | Yes | No | Yes | Yes | No | No | Yes | Yes | Yes | No | Yes | No | |
MALDI-TOF: matrix-assisted laser desorption/ionization-time of flight mass spectrometry; NRL: national reference laboratory; PCR: polymerase chain reaction; UK: United Kingdom; WGS: whole genome sequencing.
a Commercial multiplex nucleic acid amplification methods.
b Results reported for Bosnia and Herzegovina only apply to Republic of Srpska.
c Commercial loop-mediated isothermal amplification.
d Species determination, phenotypic and genotypic characterisation are not routinely performed but only upon request.
e This designation is without prejudice to positions on status, and is in line with United Nations Security Council resolution 1244/99 and the International Court of Justice Opinion on the Kosovo declaration of independence.